Goldman-led Lenders Face Losses on Arclin Debt for DuPont Unit Amid Investor Pullback
GS sits 85% above its 52-week low of $439.38.
Summary
Goldman Sachs and other lenders are reportedly facing losses on the debt they underwrote for Arclin's acquisition of DuPont's Aramids unit, as investors have pulled back from the financing. While DuPont's divestiture of the Aramids unit was a known event, with the company reporting related impairment charges in its recent 10-K, this news highlights a new challenge for the financing parties involved. For Goldman Sachs, this indicates potential hits to its lending and underwriting profitability and could signal broader difficulties in the leveraged finance market. Traders will be watching for further details on the specific magnitude of these losses and any potential impact on Goldman's future deal-making capacity or its balance sheet.
At the time of this announcement, GS was trading at $813.07 on NYSE in the Finance sector, with a market capitalization of approximately $241.3B. The 52-week trading range was $439.38 to $984.70. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.